GT Biopharma, Inc. (GTBP)
NASDAQ: GTBP · Real-Time Price · USD
0.4300
+0.0139 (3.34%)
At close: Jun 26, 2026, 4:00 PM EDT
0.4358
+0.0058 (1.35%)
After-hours: Jun 26, 2026, 7:53 PM EDT
GT Biopharma Market Cap
GT Biopharma has a market cap or net worth of $15.51 million as of June 26, 2026. Its market cap has increased by 89.11% in one year.
Market Cap
15.51M
Enterprise Value
6.58M
1-Year Change
89.11%
Ranking
Category
Stock Price
$0.43
Market Cap Chart
Since March 27, 2018, GT Biopharma's market cap has decreased from $83.20M to $15.51M, a decrease of -81.36%. That is a compound annual growth rate of -18.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 15.50M | 86.75% |
| Dec 31, 2025 | 8.30M | 22.06% |
| Dec 31, 2024 | 6.80M | -35.85% |
| Dec 29, 2023 | 10.60M | -63.19% |
| Dec 30, 2022 | 28.80M | -69.13% |
| Dec 31, 2021 | 93.30M | 181.02% |
| Dec 31, 2020 | 33.20M | 503.64% |
| Dec 31, 2019 | 5.50M | -83.13% |
| Dec 31, 2018 | 32.60M | -60.82% |
| Mar 27, 2018 | 83.20M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lunai Bioworks | 16.14M |
| Exicure | 16.06M |
| Moolec Science | 15.98M |
| Moleculin Biotech | 15.96M |
| Quince Therapeutics | 15.91M |
| Tempest Therapeutics | 15.55M |
| Atossa Therapeutics | 15.24M |
| Citius Pharmaceuticals | 14.96M |